Fluvastatin Sodium

규격

93957-55-2CAS 번호

630-467-1EC 번호

sodium (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoateIUPAC 명칭

C24H25FNNaO4화학식

433.4 g/mol분자량

FLUVASTATIN SODIUM; 93957-55-2; Fractal; Lipaxan; Lymetel; Locol; Fluvastatin sodium salt; Fluindostatin; Primesin; Lescol; Vastin; Canef; Lescol XL; Cranoc; Almastatin; Primexin; PYF7O1FV7F; Lochol; XU 62-320; DTXSID3044758; XU-62-320; DTXCID5065306; Pinmactil; Luvinsta xl; Nandovar xl; Stefluvin xl; Dorisin xl; Fluvastatin Sodium ER; RefChem:56569; CHEBI:5137; XU62320; XU 62 320; 94061-81-1; sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate; (3S,5R)-FLUVASTATIN SODIUM SALT; (3S,5R)-fluvastatin sodium; (-)-3s,5r-fluvastatin sodium salt; MFCD00929076; (3S,5R)-Fluvastatin (sodium); sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt; rel-(3S,5R,E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt; Fluvastatin Sanabo; (3s,5r)-7-(3-(4-fluorophenyl)-1-isopropyl-1h-indol-2-yl)-3,5-dihydroxyhept-6-enoic acidsodium salt; Rel-Sodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate; C24H25FNNaO4; UNII-PYF7O1FV7F; Fluvastatin sodium [USAN]; Fluindostatin;; CCRIS 6848; Primesin;; Fractal;; Lipaxan;; Lymetel;; Fluvastatin sodium [USAN:USP]; Cranoc;; Lescol;; Canef;; Locol;; Lescol (TN); (-)-fluvastatin sodium; BDS32J3EZK; SCHEMBL41663; MLS002154037; ARD193813Na; Fluvastatin sodium (JAN/USP); 3S,5R-Fluvastatin sodium salt; CHEMBL241778; orb1223582; orb1710566; FLUVASTATIN SODIUM [JAN]; CHEBI:77603; Fluvastatin sodium, (3S,5R)-; FLUVASTATIN SODIUM [VANDF]; GLXC-08139; HMS2097L19; HMS3067L20; HMS3714L19; FLUVASTATIN SODIUM [MART.]; (-)-(3S,5R)-fluvastatin sodium; (3S,5R)-(-)-fluvastatin sodium; (3S,5R)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt; FLUVASTATIN SODIUM [USP-RS]; FLUVASTATIN SODIUM [WHO-DD]; FLUVASTATIN SODIUM SALT [MI]; HY-14664C; AKOS015894901; CCG-220859; EBC-110059; FLUVASTATIN SODIUM [ORANGE BOOK]; FLUVASTATIN SODIUM [EP MONOGRAPH]; FLUVASTATIN SODIUM [USP IMPURITY]; FLUVASTATIN SODIUM [USP MONOGRAPH]; SMR000705060; Sodium (+-)-(3R*,5S*,6E)-7-(3-(p-fluorophenyl)-1-isopropylindol-2-yl)-3,5-dihydroxy-6-heptenoate; (3S,5R)-XU 62-320; CS-0019898; F0820; F4482; D00892; T10129; Q27147205; Fluvastatin sodium, European Pharmacopoeia (EP) Reference Standard; Fluvastatin sodium, United States Pharmacopeia (USP) Reference Standard; Fluvastatin for system suitability, European Pharmacopoeia (EP) Reference Standard; Fluvastatin sodium, Pharmaceutical Secondary Standard; Certified Reference Material; (+/-)-(3R*,5S*,6E)-7-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, sodium salt; (3S,5R)-rel-7-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid sodium salt; 6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, monosodium salt, (R*,S*-(E))-(+-)-; 6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,S*-(E))-(+/-)-; 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, monosodium salt, (3S,5R,6E)-; 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, monosodium salt, [R-[R*,S*-(E)]]-; 6-Heptenoic acid, 7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-, sodium salt (1:1), (3S,5R,6E)-; SODIUM (+/-)-(3R*,5S*,6E)-7-(3-(P-FLUOROPHENYL)-1-ISOPROPYLINDOL-2-YL)-3,5-DIHYDROXY-6-HEPTENOATE; sodium (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate; sodium (3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate; sodium, (e)-(3s,5r)-7-[3-(4-fluoro-phenyl)-1-isopropyl-1h-indol-2-yl]-3,5-dihydroxy-hept-6-enoate; sodium;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-isopropyl-indol-2-yl]-3,5-dihydroxy-hept-6-enoate동의어